 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture...

Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America

Procaps Group (NASDAQ: PROC) (Procaps), a leading integrated international healthcare and pharmaceutical services company, and Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB; Genomma), the...

Procaps Group says CEO Minski to step down from the role...

Procaps Group says CEO Minski to step down from the role

Procaps Group (NASDAQ: PROC) (Procaps), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today a strategic leadership transition as Ruben Minski, founder and CEO of...

Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024

Procaps Group (NASDAQ: PROC) (Procaps), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it is postponing the previously-announced earnings conference...

Procaps Group Update on Third Quarter Results

Procaps Group (NASDAQ: PROC) (Procaps), a leading integrated LatAm healthcare and pharmaceutical services company, announced it will report its results for the third quarter and nine months ended...

Procaps Group to Report Third Quarter and Nine Months 2023 Results on Tuesday November 14, 2023

Procaps Group (NASDAQ: PROC) (Procaps), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today that the National Business Association of Colombia (ANDI) and Dinero...

Procaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in Colombia

Procaps Group (NASDAQ: PROC) (Procaps or the Company), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced the appointment of one new member to its Board of...

Procaps Appoints Sandra Snchez y Oldenhage to Board of Directors

Procaps Group (NASDAQ: PROC) (Procaps), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today that it will participate at the CPHI Barcelona 2023, that will take...

Procaps Group to Participate at CPHI Barcelona 2023

Procaps Group (NASDAQ: PROC) (Procaps), a leading integrated LatAm healthcare and pharmaceutical services company, announced that it will host a webinar dedicated to the Colombian pharma market and...

Procaps Group to Host Webinar on Colombian Pharma Market

Procaps Group SA is an international healthcare and pharmaceutical company. The firm is engaged in the developing of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It operates through the following segments: NextGel, Procaps Colombia, CAN, CASAND, and Diabetrics. The NextGel segment is involved in the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in USA, Brazil, and Colombia. The Procaps Colombia segment is focused on the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in Colombia. The CAN segment deals with the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in Northern Central America: Salvador, Guatemala, Nicaragua, and Honduras. The CASAND segment offers pharmaceutical products in Southern Central America that include Panama and Costa Rica, and the North Andes District that include Ecuador, Peru, and Bolivia. The Diabetrics segment consists of the diabetes solutions and chronic disease management tool. The company was founded by Ruben Minski in 1977 and is headquartered in Luxembourg.

Watchers	379
52-Wk Low	$1.95
52-Wk High	$7.19

Market Cap	$292.78M
Volume (M)	17,314.00
52-Wk High	$7.19
52-Wk Low	$1.95

PROC Procaps Group S.A

About

Feed

News

Sentiment

Earnings

Fundamentals